Search results
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
Motley Fool via Yahoo Finance· 20 hours agopharmaceutical company. Semaglutide's sales performance has been amazing, and it's likely to be...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition - KVIA
ABC 7 El Paso· 5 days agoBy MATTHEW PERRONE AP Health Writer WASHINGTON (AP) — The Federal Trade Commission is challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic. Tuesday ...
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 4 days agoThe company's R&D expenses have increased, reflecting its commitment to discovering and...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 4 days agoThe crackdown is the latest assault against what the agency regards as drugmakers’ patent ploys...
Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoCompetition and Patent Expirations: The biopharmaceutical industry is highly competitive, with...
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 1 day agoThis financial stability is crucial for navigating the capital-intensive pharmaceutical industry and for pursuing strategic acquisitions that can further...
Decoding Johnson & Johnson (JNJ): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 days agoPatent expirations and aggressive competition pose challenges to market exclusivity. Strategic...
Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend...
Motley Fool via Yahoo Finance· 5 days agoUltra-high-yield dividend stock No. 2 billionaires are buying: Pfizer (6.61% yield) The second...
Decoding Neurocrine Biosciences Inc (NBIX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 days agoNBIX faces the constant threat of new entrants, innovative treatments, and generic competition,...
CMO/CDMO Market Expected to Reach USD 41.75 Billion by 2030: A Deep Dive into Growth Drivers
Digital Journal· 2 days agoThe Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing...